Navigation Links
Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
Date:3/13/2008

DUBLIN, Ohio, March 13 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced the appointment of company veteran Michael C. Kaufmann as group president of its Healthcare Supply Chain Services Pharmaceutical Segment.

In this role, Kaufmann, 45, will be responsible for Cardinal Health's largest business, which provides logistics services to pharmaceutical manufacturers, distributes approximately one-third of all medicine prescribed in the U.S. to hospitals, pharmacies and other providers of care, operates the nation's leading network of specialized nuclear pharmacies and is the largest franchisor of pharmacies in the U.S.

Kaufmann was most recently responsible for the turnaround of Cardinal Health's medical supply chain business and has spent the majority of his 17- year career with the company in senior operational, sales and finance roles within the pharmaceutical business. He was instrumental in strengthening financial performance within pharmaceutical distribution by leading the company's transition to a fee-based service model.

He replaces Scott A. Storrer, who will leave the company later this month. Kaufmann will continue to report to George S. Barrett, 52, vice chairman of Cardinal Health and CEO of the company's Healthcare Supply Chain Services sector.

"Mike is a proven leader and a clear choice to accelerate the turnaround of our pharmaceutical business," Barrett said. "He has deep supply chain expertise that will help us strengthen our execution and long-term customer relationships that give him a unique perspective as we work to enhance our offerings."

The company said it does not intend to fill the position Kaufmann formerly held in the medical supply chain business at this time and instead will have those senior leaders report directly to Barrett.

Kaufmann graduated from Ohio Northern University with a degree in accounting and management. He became a certified public accountant early in his career while employed by Arthur Andersen. His appointment is effective immediately.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing health care-associated infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems, MedMined(TM) electronic infection surveillance service, VIASYS(R) respiratory care products and the CareFusion(TM) patient identification system. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at http://www.cardinalhealth.com


'/>"/>
SOURCE Cardinal Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health CEO to Speak at Lehman Brothers Eleventh Annual Global Healthcare Conference
2. Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million
3. Pentec Health Taps Former Cardinal Health Executive Joseph Cosgrove as Chief Executive Officer
4. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
5. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
7. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
8. Cardinal Health to Announce Second-Quarter Results on January 29
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
11. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... Establishment Labs, a global breast implant and medical technology company, is pleased ... , “We are honored to welcome David to our Board of Directors. ... Quiros, CEO of Establishment Labs. "David’s knowledge and experience will be invaluable to our ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has ... CEO of Freedom Laser Therapy , was determined to find solutions to his problems ... story of Inventors Digest is ready to introduce his breakthrough inventions to the ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
Breaking Medicine Technology: